As part of our series focussing on medicines available in Australia, we have added a product review of the use of prolonged-release intramuscular risperidone for treating schizophrenia in adults.
This review summarises indications and dosage, contraindications and a series of clinical studies featuring prolonged-release risperidone. It also provides commentary and guidance from Professor Nagesh Pai, Senior Clinical Academic at the Older Persons Mental Health Services at Illawarra Shoalhaven Local health District.
Please login below to download this issue (PDF)